They’re making glaucoma-treating stents, tumor-treating fields, coin-sized CGMs and more. Discover the medtech companies that spend the most on research as a percentage of revenue. The list comes from our annual Big 100 report, which examines the world’s 100 largest medical device companies and ranks them by revenue. (Check out our full Big 100 report […]
Freenome raises $290M from Roche
Freenome said today that it has raised $290 million from Roche to advance its cancer early detection platform, which uses a routine blood draw. The South San Francisco, California–based company has raised more than $1.1 billion since its founding in 2014. “With Roche’s investment and expertise, we’ll be able to further accelerate and augment the […]
Withings buys Impeto Medical
Withings announced today that it will acquire Impeto Medical and its technology for detecting and tracking peripheral neuropathies. The financial terms of the deal were not disclosed. Withings plans to first use the Impeto Medical tech in its Body Scan smart scale platform, which it announced last week at CES 2022. Body Scan boasts a […]
iRhythm scores an important reimbursement win
iRhythm Technologies (NSDQ:IRTC) and other companies pioneering remote external EKG monitoring have scored a significant reimbursement win. The regional Medicare administrative contractor Novitas Solutions has set CPT codes 93243 and 93247 at roughly $223 and $233 respectively — news first reported by analysts this morning. The rates are retroactive to Jan. 1, 2022. “We would […]
ICU Medical completes $2.35B purchase of Smiths Medical
ICU Medical (NASDAQ:ICUI) recently announced that it has completed its $2.35 billion acquisition of Smiths Medical from the Smiths Group. Smiths Medical’s business includes syringe and ambulatory infusion devices, vascular access, and vital care products. The merger creates an infusion therapy company with estimated annual revenues of roughly $2.5 billion, ICU Medical said in a […]
Hologic says Q1 results will be better than expected
Hologic (Nasdaq: HOLX) announced preliminary Q1 revenue numbers that beat its previous projections, as well as the expectations of The Street. The Marlborough, Massachusetts–based company brought in revenue of roughly $1.47 billion for the quarter ended December 25, 2021, down 8% from the same quarter a year before but well above its most recent guidance […]
MeMed raises $93M for its host immune-response product portfolio
MeMed announced today that it has raised $93 million to boost the manufacturing and commercialization of its host immune response diagnostics. The company, based out of Haifa, Israel and Boston, has raised a total of $200 million, including support from the U.S. Department of Defense and EU Commission. The latest money-raise includes new and existing […]
Cardinal Health’s Medical segment is performing worse than expected
Cardinal Health (NYSE:CAH) stock is taking a hit today after the company announced that it was cutting profit projections for its Medical segment. The Dublin, Ohio–based company reported that it expected its Medical segment to face additional inflationary impacts and lower volumes resulting primarily from global supply chain constraints. There is also a lower-than-expected offset […]
Abbott sees the delivery system as a differentiator for its TAVR
A top Abbott executive explains how the company’s FlexNav delivery system could make the Portico TAVR competitive. Abbott is aiming to claw away market share from transcatheter aortic valve replacement pioneers Edwards Lifesciences and Medtronic. The Abbott Park, Illinois–based medtech company in September announced FDA approval of its Portico with FlexNav TAVR system, more than […]
The top 5 medtech news stories of 2021
The past year saw significant changes in the medtech space. Our editorial team picked their top stories. The lingering COVID-19 pandemic was top of mind in 2021, but there was much more going on in the medical device industry. The Life Sciences editorial team here at WTWH Media discussed their top picks during the December […]
Oracle to buy Cerner for $28.3B
Oracle Corp. (NYSE: ORCL) will spend $28.3 billion to acquire Cerner Corp., the two companies announced today. Cerner is a significant provider of digital information systems used within hospitals and health systems. Get the full story on our sister site Medical Design & Outsourcing.